abstract |
The present invention is directed to dichlorohydric acid salts and dibenzenesulfonic acid salts of the c-Met kinase 2-fluoro-N-methyl-4- [7- (quinolin-6-ylmethyl) imidazo [1,2-b] inhibitor [1,2,4] triazin-2-yl) benzamide, and pharmaceutical compositions thereof, useful in the treatment of cancer and other diseases related to the deregulation of the kinase pathways. The present invention further relates to intermediary processes for preparing 2-fluoro-N-methyl-4- [7- (quinolin-6-ylmethyl) imidazo [1,2-b] [1,2,4] triazin-2 -il) benzamide and salts thereof .. |